Many fans are curious about John Kapoor's financial success in April 2026. In this article, we dive deep into the assets and career highlights.

What Is John Kapoor's Net Worth?

In 1989, Kapoor sold Lyphomed to the Japanese company Fujisawa for nearly $1 billion. His cut from the sale was $130 million—a massive return on his tiny initial investment. He re-invested his wealth into dozens of startups and acquired significant stakes in larger enterprises. John became the biggest shareholder in at least five biotech firms, including Akorn, First Horizon, and Neopharm most of which dealt in generic drugs.

Within a decade, Lyphomed grew from 20 to around 800 employees, and sales skyrocketed to 25 times their original figure. The 1980s brought even more opportunities for the company. As the AIDS epidemic ravaged communities, Lyphomed held a near monopoly on pentamidine, an antibiotic used to treat deadly pneumonia infections in AIDS patients.

John Kapoor is an American entrepreneur who has a net worth of $50 million. At his peak in 2017, with his company's stock price soaring, John Kapoor's net worth was just under $2 billion. In October 2017, John was arrested on RICO and wire fraud charges. He was found guilty on all charges and served 2.5 years in prison. In 2019, his company filed for bankruptcy. John Kapoor was played byAndy Garciain the 2023 Netflix crime drama "Pain Hustlers," starringEmily BluntandChris Evans.

The 1980s were a golden age for generic drug companies as a bunch of big-name drugs were going off-patent. Kapoor turned into a vulture constantly circling the pharmaceutical giants, waiting to swoop in with a cheaper, generic copy of their branded products once they went off-patent. He was so relentless that his generic drugs would hit the market at midnight on the very day a patent expired in order to beat the flock of competitors to the market.

Kapoor bought Lypho-Med for a steal thanks to a loan from a Chicago-based bank, a small personal investment of around $50,000, and capital from some investors. He became the bossman and took the company public, steering the whole operation. John then changed the company's name to Lyphomed and expanded the business into selling hundreds of injectable medications to hospitals.

(Photo by Pat Greenhouse/The Boston Globe via Getty Images)

John Nath Kapoor was born in 1942 in Amritsar, Punjab, India, into a humble background. He later moved to Mumbai, where he graduated from the Institute of Chemical Technology (formerly UDCT) with a degree in pharmacy. His academic pursuits later led him to the United States, where he attended the University at Buffalo on a scholarship and obtained a doctorate in medicinal chemistry in 1972.

With a fresh Ph.D. in hand, Kapoor plunged into the job market. He started out in operations at a small drug company in Grand Island, New York, called Invenex Pharmaceutical. Soon afterward, John approached the senior execs at Stone Container, a cardboard box manufacturer, with a bold proposition: let him run Lypho-Med, their neglected generic drug subsidiary in Chicago. Despite a warning that Stone Container intended to sell the drug business he confidently negotiated for a job as General Manager and the right of first refusal for when the company would go up for sale.

Ultimately, John Kapoor's financial journey is a testament to their success.

Disclaimer: All net worth figures are estimates based on public data.